Clinical Trials Directory

Trials / Completed

CompletedNCT04931836

The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
77 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
30 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The present study is a 100-participant randomized controlled 2-arm parallel trial that employs a metagenomic approach to examine how 8 weeks of supervised moderate-intensity treadmill walking exercise (MWE) for 30-45 min 3 times/week alters the gut microbiome, serum short chain fatty acids, and the cardiometabolic profile, body weight, and body composition of individuals 30-64 years old who have overweight or obesity and have prediabetes.

Detailed description

All eligible and consented participants will complete a 3-week run-in phase during which baseline outcome assessments will be performed. During run-in weeks 1 and 2, participants will wear a Fitbit Inspire 2 smartwatch and complete three unannounced dietary recalls. During the run-in week 3 (see table below), participants will consume their 3-day standardized meal plan on days three through five, obtain a fecal sample, complete a study questionnaire, and complete a study assessment visit. To quantify compliance with the 3-day meal plan, participants will be provided with a paper checklist of all foods to be consumed, and will be asked to indicate which foods were consumed and to document any deviation. The study assessment visit will include a fasting blood draw (at baseline and week eight only), blood pressure in triplicate, weight measure and body fat assessment in duplicate, and a saliva sample.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical Activity InterventionThree walking sessions/week for a total of 8 weeks (24 total sessions) - Walking sessions will either take place on new commercial treadmills in the Epidemiology Clinical Research Center or remotely at or around a participant's home. Regardless of the walking location, walking sessions will be 30 min in duration during intervention weeks 1 through 4 and a minimum of 45 min each during intervention weeks 5 through 8.

Timeline

Start date
2021-07-29
Primary completion
2023-11-30
Completion
2023-11-30
First posted
2021-06-18
Last updated
2025-06-13
Results posted
2025-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04931836. Inclusion in this directory is not an endorsement.